Brief: Astellas Pharma Inc- Notice Regarding Progress In Core Business, Impairment Loss And Revision Of Financial Forecasts For Fy2024
24/01/2025 07:14
Astellas Pharma Inc 4503.T :
* ASTELLAS PHARMA INC- NOTICE REGARDING PROGRESS IN CORE
BUSINESS,
IMPAIRMENT LOSS AND REVISION OF FINANCIAL FORECASTS FOR FY2024
Source text: ID:nTSmx87802
Further company coverage: 4503.T
Recent news on Astellas Pharma
See all newsFocus: Trump's push for the world's lowest drug prices hits snag with mid-sized companies
China detains two Japanese nationals suspected of smuggling banned goods (updated)
Brief: Astellas Pharma: Institutional Shareholder Services Has Issued A Report Recommending A Vote Against A Director Candidate
Health Rounds: Veracyte genomic test identifies breast cancer patients who can skip chemo
Advisory: Alert wrongly tagged to Gold Rain Enterprises withdrawn